EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors
HTML-код
- Опубликовано: 1 мар 2022
- Adriaan Voors discusses the EMPULSE trial of empagliflozin given just after stabilization of de novo or decompensated chronic heart failure (5:21).
View more on Medicine Matters diabetes: diabetes.medicinematters.com/ and remember to Like this video and Subscribe to our channel. 
Наука
